AzTrials
AzTrials

Autistic DisorderNCT00382382

Diffusion Tensor Imaging in Autism

A study testing diffusion tensor imaging (DTI) in people with Autistic Disorder, run by University of Florida at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Using a new and more detailed approach to diffusion tensor imaging (DTI) recently developed in our lab, the investigators hope to learn more about irregularities in the brain that are related to autism. Read more about this study

Who is it for?
Ages 8 to 12 years, men onlyHealthy volunteers can take part
Conditions the study is for
Autistic Disorder
What is being tested?
diffusion tensor imaging (DTI)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Jul 2008to Jul 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • Men only
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • male, aged 8-12 years of age
  • clinical diagnoses of autism from a licensed professional for Autism or Asperger's Syndrome
  • IQ >80
  • no speech delay
  • no major sensory or motor deficits

Who cannot join

  • known genetic or medical conditions (e.g. Fragile X syndrome, tuberous sclerosis, Turner's syndrome)
  • currently (within prior 3 months) taking anti-psychotic/dopamine-modulating medications

Trial locations and contacts

1 site in 1 country.

United States1 site
  • McKnight Brain Institute of the University of Florida

    Gainesville, Florida, 32611

Other trials in United States

About this study

Using a new and more detailed approach to diffusion tensor imaging (DTI) recently developed in our lab, the investigators hope to learn more about irregularities in the brain that are related to autism. The investigators are especially interested in brain regions that contribute to repetitive behaviors in children with autism. Repetitive behaviors include stereotyped motor movements (hand-flapping), self-injurious behaviors (head hitting), compulsions (lining up toys), insistence on things staying the same, and difficulty with change. These behaviors often interfere with learning, can disrupt daily functioning, and can lead to other behavioral problems. Two specific aims will be accomplished:

Aim 1: To examine the integrity of white matter pathways in high functioning autistic children. The investigators hypothesize that autism is associated with specific white matter abnormalities in the cerebellum and other motor circuits. Additionally, the investigators expect to confirm and expand on previous reports of cerebral abnormalities by using newly developed DTI methods.

Read more

Aim 2: To determine whether there is a relationship between white matter abnormalities and the occurrence of restricted repetitive behaviors in children with autism. The investigators hypothesize that differences in the occurrence and type of restricted repetitive behaviors between autistic individuals are correlated with specific regional white matter abnormalities.

Results from the proposed experiments should contribute to current knowledge of brain abnormalities in autism and their relationship to restricted repetitive behaviors, and may be relevant to understanding the mechanisms underlying motor deficits in this disorder.

Read the detailed description

Using a new and more detailed approach to diffusion tensor imaging (DTI) recently developed in our lab, the investigators aim to confirm and expand upon previous findings of white matter abnormalities throughout the brain in individuals with autism. The investigators have chosen to focus particularly on cerebellar and motor pathways in consideration of the prevalence of motor deficits in autism as well as brain structural studies that have indicated cerebellar abnormalities in autistic children. Finally, a proposal to investigate a possible functional association between white matter structure and the expression of restricted repetitive behaviors in autistic children, by correlating measures of white matter integrity with behavioral assessments indicating the severity of various forms of restricted repetitive behaviors. Two specific aims will be accomplished. Aim 1: To examine the integrity of white matter pathways in high functioning autistic children. The hypothesis is that autism is associated with specific white matter abnormalities in the cerebellum and other motor circuits. Additionally, it is expect to confirm and expand on previous reports of cerebral abnormalities by using newly developed DTI methods. Aim 2: To determine whether there is a relationship between white matter abnormalities and the occurrence of restricted repetitive behaviors in children with autism. The hypothesis is that differences in the occurrence and type of restricted repetitive behaviors between autistic individuals are correlated with specific regional white matter abnormalities. Results from the proposed experiments should contribute to current knowledge of brain abnormalities in autism and their relationship to restricted repetitive behaviors, and may be relevant to understanding the mechanisms underlying motor deficits in this disorder.

Being tested
diffusion tensor imaging (DTI)
Keywords
Autism, Asperger Syndrome, Restricted repetitive behavior, Stereotyped patterns of behavior, Typically Developing children, Human Volunteers
Medical subject headings
Autistic Disorder, Asperger Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • diffusion tensor imaging (DTI)Other

    Both groups will have a diffusion tensor imaging (DTI) perform.

Study groups in NCT00382382
Study groupRoleWhat they receive
Children with AutismOtherA diffusion tensor imaging (DTI) will be done to examine the integrity of the white matter pathways in high functioning austistic children.
Receives: Other: diffusion tensor imaging (DTI)
Healthy VolunteersOtherA diffusion tensor imaging (DTI) will be done to examine the integrity of the white matter pathways in healthy volunteers.
Receives: Other: diffusion tensor imaging (DTI)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. RBS-R scores, including both total and subset scores

    Measured: once

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2006 (estimated)
  2. Study startJul 2008
  3. Primary completionJul 2009
  4. Study completionJul 2009

Why it stopped: Study was completed but there were no participants. It was completed as a theoretical study. Requests for final progress report can be sent to Dr. Liu.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00382382
Sponsor's protocol ID
1R03HD051656
Status last verified
Mar 2015
First submitted
28 Sep 2006
Last updated
13 Mar 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing diffusion tensor imaging (DTI) in people with Autistic Disorder, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 13 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

RBS-R scores, including both total and subset scores (time frame: once). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2015; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in